Your browser doesn't support javascript.
loading
Chondroitin Sulfate Proteoglycan 4 as a Marker for Aggressive Squamous Cell Carcinoma.
Chen, Kathryn; Yong, Joel; Zauner, Roland; Wally, Verena; Whitelock, John; Sajinovic, Mila; Kopecki, Zlatko; Liang, Kang; Scott, Kieran Francis; Mellick, Albert Sleiman.
Afiliação
  • Chen K; Ingham Institute for Applied Medical Research, Medicine, University of New South Wales, Liverpool, NSW 2170, Australia.
  • Yong J; School of Medicine, Western Sydney University, Campbelltown, NSW 2560, Australia.
  • Zauner R; Ingham Institute for Applied Medical Research, Medicine, University of New South Wales, Liverpool, NSW 2170, Australia.
  • Wally V; School of Chemical Engineering, University of New South Wales, Kensington, NSW 2033, Australia.
  • Whitelock J; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology & Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
  • Sajinovic M; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology & Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
  • Kopecki Z; Ingham Institute for Applied Medical Research, Medicine, University of New South Wales, Liverpool, NSW 2170, Australia.
  • Liang K; Graduate School of Biomedical Engineering, University of New South Wales, Kensington, NSW 2033, Australia.
  • Scott KF; Ingham Institute for Applied Medical Research, Medicine, University of New South Wales, Liverpool, NSW 2170, Australia.
  • Mellick AS; Future Industries Institute, University of South Australia, Mawson Lakes, SA 5095, Australia.
Cancers (Basel) ; 14(22)2022 Nov 13.
Article em En | MEDLINE | ID: mdl-36428658

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália